课题基金 / 基金详情

GENE DELIVERY TO THE PRIMATE CNS--VIRAL VECTORS

GENE DELIVERY TO THE PRIMATE CNS--VIRAL VECTORS
灵长类中枢神经系统的基因传递——病毒载体
批准号:
6151488
负责人:
DONALD EUGENE REDMOND
金额:
$51.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2002-07-01

项目摘要

项目成果

DONALD EUGENE REDMOND的其他基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):在灵长类CNS中, 拟议的研究旨在测试和比较可能的基因治疗载体 来源于三组病毒:重组单纯疱疹病毒 (HSV)腺病毒(Ad)和腺相关病毒(AAV)。 虽然这些 虽然已经在啮齿动物CNS中研究了载体,但很少有研究涉及 安全性、最佳递送、载体在特定细胞中表达 群体,转基因表达的持续性,以及推定的转基因的功能。 治疗基因在灵长类动物中枢神经系统的系统方式。 HSV、Ad和 已经显示AAV载体能够包装和递送基因, 序列的啮齿动物中枢神经系统,和优点,缺点和选择性 每一个都有自己的特点。 病毒库存窝藏的细胞 标记基因、核定位lacZ(lacZnl)或人神经胶质细胞系 衍生的神经营养因子(GDNF),将被生产和质量控制。 最初的研究将涉及递送方法,转导效率, 从注射部位扩散,包括逆行转运、细胞 向性、载体持久性、稳定性和转基因表达水平, 神经病理学和宿主细胞反应。 系统性挑战, 还将研究病毒以解决安全性和免疫反应问题。 将选择一种载体以将GDNF或失活突变GDNF递送至 评估功能。 GDNF具有良好的形态学、生物化学和生物学特性, 对多巴胺神经元的功能影响,这与许多 更高的大脑功能和运动控制。 我们将评估认知和 运动的影响载体交付GDNF在两个脑区,前额叶 皮质和尾状核,MPTP诱导的多巴胺耗竭后, 猴子 功效的测量将包括行为参数、分子生物学参数、生物学参数和生物学参数。 使用ELISA测定蛋白质,RT-PCR测定mRNA, 载体DNA的PCR,DA及其代谢产物的生化测定, 神经解剖学和形态测量学分析,神经病理学,以及 放射自显影 这些研究的目的是提供有关病毒载体的基本信息, 灵长类动物中枢神经系统通过综合,比较实验设计。 的 多巴胺耗竭和GDNF对认知和运动影响的选择 测试灵长类动物大脑中基因治疗功能结果的基因是 基于这些效应在灵长类动物中的良好表征性质, GDNF在啮齿类和灵长类动物中的作用,包括GDNF基因 在啮齿动物多巴胺耗竭模型中的治疗。 然而,主要目的是 这些研究有助于开发有效和安全的基因工程药物。 递送系统,用于未来广泛应用于人类CNS, 条件
英文摘要
DESCRIPTION (Adapted from applicant's abstract): In the primate CNS, the proposed studies aim to test and compare possible vectors for gene therapy derived from three groups of viruses: recombinant herpes simplex virus (HSV), adenovirus (Ad) and adenoassociated virus (AAV). Although these vectors have been studied in the rodent CNS, few studies have addressed the issue of safety, optimal delivery, vector expression in specific cell populations, persistence of transgene expression, and function of putative therapeutic genes in a systematic fashion in the primate CNS. HSV, Ad and AAV vectors have been shown to be capable of packaging and delivering gene sequences to the rodent CNS, and advantages, disadvantages and selectivity inherent to each have been identified. Viral stocks harboring the cellular marker gene, nuclear localized lacZ (lacZnl) or human glial cell line derived neurotrophic factor (GDNF), will be produced and quality controlled. Initial studies will address methods of delivery, transduction efficiency, spread from the site of injection including retrograde transport, cellular tropism, vector persistence, stability and level of transgene expression, neuropathology and host cellular responses. Systemic challenge with related viruses also will be studied to address safety and immune responses. One vector will be selected to deliver GDNF or an inactive mutant GDNF to assess function. GDNF has well documented morphological, biochemical and functional effects on dopamine neurons, which are associated with many higher brain functions and with motor control. We will assess cognitive and motor effects of vector-delivered GDNF in two brain areas, the prefrontal cortex and the caudate nucleus, after MPTP-induced dopamine depletions in monkeys. Measures of efficacy will include behavioral parameters, molecular assays of transgene expression using ELISA for protein, RT-PCR for mRNA and PCR for vector DNA, biochemical assays of DA and its metabolites, neuroanatomical and morphometric analyses, neuropathology, and autoradiography. These studies aim to provide fundamental information on viral vectors in the primate CNS through an integrated, comparative experimental design. The choice of cognitive and motor effects of dopamine depletion and the GDNF gene to test functional outcomes of gene therapy in the primate brain are based on the well characterized nature of these effects in primates and the reported effects of GDNF in rodents and primates, including GDNF gene therapy in rodent dopamine depletion models. However, the major aim of these studies is to contribute to the development of effective and safe gene delivery systems for future application to the human CNS for a wide range of conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GDNF Delivery to MPTP Monkeys by EIAV lentivirus and AAV
  • 批准号:
    7059939
  • 项目类别:
  • 资助金额:
    $104.58万
  • 财政年份:
    2004
  • 负责人:
    DONALD EUGENE REDMOND
  • 依托单位:
GDNF Delivery to MPTP Monkeys by EIAV lentivirus and AAV
  • 批准号:
    6726415
  • 项目类别:
  • 资助金额:
    $111.85万
  • 财政年份:
    2004
  • 负责人:
    DONALD EUGENE REDMOND
  • 依托单位:
GDNF Delivery to MPTP Monkeys by EIAV lentivirus and AAV
  • 批准号:
    6888933
  • 项目类别:
  • 资助金额:
    $103.98万
  • 财政年份:
    2004
  • 负责人:
    DONALD EUGENE REDMOND
  • 依托单位:
GDNF Delivery to MPTP Monkeys by EIAV lentivirus and AAV
  • 批准号:
    7228455
  • 项目类别:
  • 资助金额:
    $104.59万
  • 财政年份:
    2004
  • 负责人:
    DONALD EUGENE REDMOND
  • 依托单位: